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Summary
A universal molybdenum-containing cofactor (MoCo) is
essential for the activity of all human molybdoenzymes,
including sulphite oxidase. The free cofactor is highly
unstable, and all organisms share a similar biosynthetic
pathway. The involved enzymes exhibit homologies,
even between bacteria and humans. We have exploited
these homologies to isolate a cDNA for the heterodi-
meric molybdopterin (MPT)-synthase. This enzyme is
necessary for the conversion of an unstable precursor
into molybdopterin, the organic moiety of MoCo. The
corresponding transcript shows a bicistronic structure,
encoding the small and large subunits of the MPT-syn-
thase in two different open reading frames (ORFs) that
overlap by 77 nucleotides. In various human tissues,
only one size of mRNA coinciding with the bicistronic
transcript was detected. In vitro translation and muta-
genesis experiments demonstrated that each ORF is
translated independently, leading to the synthesis of a
10-kDa protein and a 21-kDa protein for the small and
large subunits, respectively, and indicated that the 3′-
proximal ORF of the bicistronic transcript is translated
by leaky scanning.
Introduction
In eukaryotic molybdoenzymes, the catalytically active
metal molybdenum is complexed by a unique cofactor,
termed the “molybdenum cofactor” (MoCo), that com-
bines with diverse apoproteins in which it is responsible
for the correct anchoring and positioning of the Mo-
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center within the holoenzyme (reviewed by Hille [1996]
and Stiefel [1996]). The structural moiety of MoCo was
identified as a unique pterin, designated “molybdop-
terin” (MPT; reviewed by Rajagopalan and Johnson
[1992]) and has been shown to be identical in all or-
ganisms. Accordingly, the MoCo biosynthetic pathway
seems to be conserved, because highly homologous pro-
teins have been found to be involved in MoCo biosyn-
thesis in bacteria and higher plants (reviewed by Mendel
[1997]).
In Escherichia coli, in which the genes and proteins
relevant to MoCo biosynthesis have been intensively
studied, the synthesis of MoCo proceeds in three steps
(reviewed by Rajagopalan [1996]): (1) conversion of
GTP into the stable precursor Z; (2) conversion of pre-
cursor Z into MPT; and (3) insertion of molybdenum
into MPT, thus forming MoCo. Human MoCo defi-
ciency is a rare and fatal disease (Johnson and Wadman
1995). It is inherited in an autosomal recessive manner
and results in neurologic damage leading to death in
early childhood. Johnson et al. (1989) used fibroblasts
from MoCo-deficient patients to define two comple-
mentation groups, which correspond to type A (MIM
252150) and type B (MIM 252160) of MoCo deficiency.
It was assumed that type A patients are defective in the
early steps of MoCo biosynthesis leading to precursor
Z. This was recently confirmed by the identification of
mutations in MOCS1 (Reiss et al. 1998b). The MOCS1
transcript is bicistronic, and mutations were found in
both of the two consecutive open reading frames (ORFs)
encoding MOCS1A and MOCS1B. Translation reinitia-
tion was suggested as the mechanism of translation for
the second ORF.
In E. coli, MPT-synthase is composed of two subunits,
the small subunit (10 kDa) encoded by the moaD gene,
and the large subunit (16 kDa) encoded by the moaE
gene (GenBank; Pitterle et al. 1993). Here we describe
the isolation and analysis of a human cDNA, MOCS2,
encoding proteins homologous to the bacterial MPT-
synthase, which involves two unexpected findings: (1)
in humans, both subunits of MPT-synthase are again
encoded by a single gene comprising two ORFs; and (2)
the two ORFs overlap. To understand the translation of
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this unique genetic construct, in vitro mutagenesis ex-
periments were performed. We show that both subunits
of the MPT-synthase are translated independently, and
provide evidence for leaky scanning as the mechanism
of translation from this mRNA.
Material and Methods
Screening of a Human Liver cDNA Library
An aliquot containing 100,000 Pfu of an adult human
liver cDNA library (Stratagene), subcloned into the l
vector UNI-ZAP, was hybridized with a 32P-labeled BglII/
EcoRI fragment, representing a 5′-truncated MOCS2
cDNA clone from human fetal liver, obtained from the
IMAGE consortium. Hybridization was performed ac-
cording to Sambrook et al. (1989) at 65C in 5 x SSPE,
5 x Denhardt, 1% SDS, and 1% sonicated calf thymus
DNA. The filters were washed at 65C in 20.1 x SSPE
and 0.1% SDS. The random primed–labeling method,
following Feinberg and Vogelstein (1984), was used to
label the MOCS2 BglII/EcoRI fragment. Positive clones
were verified in a second screen and transferred to p-
Bluescript SK (pBSK) constructs by means of the in
vivo excision system of the UNI-ZAP vector, according
to the manufacturer’s instructions. We determined the
nucleotide sequence of the resulting plasmids using the
automatic sequencer ABI Prism 310 and the DNA Se-
quencing Kit (PE Applied Biosystems).
Northern Blot Analysis
A human multiple-tissue northern blot (MTN, Clon-
tech) was hybridized with the 32P-labeled 1.35-kb
MOCS2 EcoRI/XhoI fragment, according to the man-
ufacturer’s instructions. The random primed–labeling
method was used to label the EcoRI/XhoI fragment
(Feinberg and Vogelstein 1984). After hybridization, the
filter was exposed to Kodak X-OMAT AR film.
Plasmid Construction
To subclone the MOCS2 cDNA from pBSK into the
vector pHST07, a derivate of pHST0 (Jobling et al.
1988) optimized for in vitro transcription of mRNA,
PCR amplification was performed to generate a BglII
site in front of the 5′ end of the cDNA fragment and a
SalI site in the 3′ UTR of the cDNA sequence. Primer 1
was 5′-GTCCTACGATCCAGATCTGCAGGAATTC-
GGCACGAGCG. Primer 2 was 5′-CTTTCCAGTTCT-
GTCGACATTCCTGTCAGC. The PCR fragment was
cleaved by BglII and SalI and subcloned into the BglII/
SalI site of pHST07 (pMOCS2). To mutate the initiator
codon of the MOCS2A ORF from ATG to TTG, primer
3 (5′-AATTCGGCACGAGATCTGTCCTAGGCGGG-
TTGGTGCCGCTG) was used, together with primer 2
(pMOCS2A*). Primer 4 (5′-GCACGAGGAGCGGAT-
CCCCAAGCTCGACAAATTCTTGACGAACAGC) is
complementary to nucleotides 202 to 247 of MOCS2,
except for CAA (bold) complementary to TTG (which
replaces ATG), and the mutation of the G(231) to C and
of the C(236) to G, to form a BamH1 site (underlined),
was used with primer 1 to amplify fragment 1. Primer
5 (5 ′-ATGTCGAGCTTGGGGATCCGCTCCTCG-
TGC) is homologous to nucleotides 218–247 of
MOCS2, except for the replacement of A(231) by G and
A(236) by C to form a BamH1 site (underlined), and
was used in conjunction with primer 2 to synthesize
fragment 2. PCR fragment 1 was cleaved with BglII and
BamHI, and PCR fragment 2 with BamH1 and SalI, and
the two fragments ligated simultaneously into the BglII
and SalI sites of plasmid pHST07 (pMOCS2B*). In all
PCR reactions, cloned Pfu DNA polymerase (Stratagene)
was used according to the supplier’s recommendations.
PCR fragments were purified with use of the QIAquick
PCR Purification Kit (Qiagen). All constructs were ver-
ified by sequencing. pMOCS2DA and pMOCS2DAB are
5′ truncated versions of the pMOCS2 full-length clone,
obtained from the screening of the adult human liver
cDNA library; they lack nucleotides 1–120 (p-
MOCS2DA) and nucleotides 1–232 (pMOCS2DAB) of
the full-length MOCS2 cDNA sequence, respectively.
In Vitro Transcription
We prepared and purified Plasmids by using Nucleo-
bond Ax cartridges (Macherey Nagel), as indicated by
the supplier. Plasmids pMOCS2DA and pMOCS2DAB
in pBSK were linearized by XhoI and transcribed by T3
RNA polymerase (Eurogentec). Plasmids pMOCS2,
pMOCS2A*, and pMOCS2B* in pHST07 were linear-
ized by SalI and transcribed by T7 RNA polymerase
(BRL). To produce capped transcripts, the linearized
DNA (2 mg) was incubated in a 100-ml mixture con-
taining 1 # buffer for T3 or T7 RNA polymerase (as
specified by the suppliers); 10 mM DTT; 50 mg/ml BSA
(BRL); 100 U RNAsin (Promega); 0.5 mM each of ATP,
CTP, and UTP; 0.2 mM GTP; and 1 mM m7GpppG
(Pharmacia); as well as 30 U or 250 U, respectively, of
T3 or T7 RNA polymerase, as required. After 1 h at 37
C, 30 U or 125 U, respectively, of T3 or T7 RNA poly-
merase were added. Total incubation was for 2 h at
37C. The template DNA was then destroyed by incu-
bation for 10 min at 37C with 2 U RQ1 DNase (Pro-
mega), after which 2 mM EDTA (pH 8) was added to
inhibit the DNase. The RNA was purified by passage
through a Sephadex G-50 column, followed by phenol
and chloroform extraction and ethanol precipitation.
The integrity and size of the transcripts were estimated
by native agarose gel electrophoresis, and the concen-
tration was determined by A260 measurements. The
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Figure 1 Nucleotide sequence (nucleotides belonging to the
cDNA linker are printed in italics). The MOCS2A ORF is located at
the 5′ end (nucleotides 31–294). The MOCS2B ORF starts at the 3′
end of the MOCS2A ORF (nucleotides 218–781). In MOCS2B, the
region of homology starts after the second in-frame ATG (position
323, Met in position 36) of the full-length protein. A, Deduced amino
acid sequence. The positions of the in-frame ATG codons are under-
lined. B, Schematic representation of the human MOCS2 cDNA clone
(adult liver). Regions homologous to the E. coli MoaD and MoaE
proteins are highlighted by a bold line (B). The positions of the in-
frame ATG codons are indicated by a star below the ORFs. The cal-
culated sizes of the resulting translation products are indicated below
the horizontal arrows, the 5′ ends of pMOCS2DA and pMOCS2DAB
by bent arrows. CNBR cleavage sites are indicated by the small bent
arrows.
transcripts are designated by the name of the construct
preceded by the prefix “t.”
In Vitro Translation
Capped transcripts (400 ng), preheated for 10 min at
65C ,were incubated for 1 h at 30C by use of 560 kBq
of [35S]methionine or 370 kBq [35S]cysteine (Amersham)
as specified, in 10 ml translation mixture containing 4
ml ribonuclease-treated rabbit reticulocyte lysate (Amer-
sham), as described by the supplier, in the presence of
130 mM KCl and 1.5 mM Mg acetate. When indicated,
0.25 mM cap analogue m7GTP (Sigma) was added to
the incubation mixture. Aliquots (2 ml) of the translation
products were analyzed on a 16.5% acrylamide-Tricine/
SDS gel system (Scha¨gger et al. 1987). After electropho-
resis, the gels were fixed, processed for fluorography
with Amplify (Amersham), dried, and placed under an
x-ray film. When required, the relevant bands were cut
from the dried gel and their radioactivity was measured
in 3 ml OptiScint “HiSafe” scintillation mixture (Wal-
lac). The ratio of the radioactivity contained in the 21-
kDa or 10-kDa protein bands in the presence versus in
the absence of cap analogue was determined.
Results
Using the amino acid sequence of the E. coli MoaE
protein, we performed a blast N search in the National
Center for Biotechnology Information expressed se-
quence tag database (GenBank), leading to the identi-
fication of a fetal human liver cDNA clone homologous
to the C-terminal part of the E. coli MoaE protein, the
large subunit of the MPT-synthase. The clone was ob-
tained from the IMAGE consortium (Lennon et al.
1995), and further sequence analysis revealed that it rep-
resents a 1-kb cDNA with an N-terminal truncated ORF
encoding an MoaE homologous protein. To obtain a
full-length cDNA clone, we screened an adult human
liver cDNA library, using this 5′-truncated cDNA clone
as probe. This led to the isolation of six independent
cDNA clones varying from 1.35 kb–1.1 kb. Nucleotide
analyses revealed that the shorter cDNAs represent 5′-
truncated versions of the 1.35-kb clone. Sequence anal-
ysis of the 1.35-kb cDNA clone showed that it represents
a cDNA of 1,345 bp with a full-length MoaE homol-
ogous ORF encoding a protein of 188 amino acids, with
a calculated size of 20.8 kDa and 29.3% identity to the
amino acid sequence of the E. coli MoaE protein (fig.
1). Surprisingly, 5′ of the MoaE homologous ORF, a
second ORF could be identified, encoding a protein of
88 amino acids with a calculated size of 9.8 kDa. Com-
parison of the amino acid sequence of the protein en-
coded by this latter ORF revealed that it shows 27.5%
identity to the E. coli MoaD protein, the small subunit
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Figure 2 Multiple alignments of the MOCS2A (A) and
MOCS2B (B) homologous proteins. Identical amino acids are in black,
similar amino acids in grey. Identical positions in all sequences are
indicated by a capital letter in the consensus line, highly conserved
residues in lowercase letters. Sequences of the eubacterial homologues
from E. coli, Haemophilus influenzae, Rhodobacter sphaeroides, Sy-
nechoccus spec. PCC 7942, and Synechocystis spec. PCC 6803 were
obtained from GenBank, as well as the sequence of the MOCS2A and
MOCS2B homologues of Caenorhabditis elegans. The Arabidopsis
thaliana sequence homologous to the human MOCS2B protein is from
protein Cnx6 (R. R. Mendel, unpublished results).
of the MPT-synthase. The ORFs are arranged in different
reading frames and overlap by 77 bp.
Since the isolated 1.35-kb cDNA clone represents the
second human cDNA clone involved in the human
MoCo biosynthesis pathway, it has been named MOCS2
(molybdenum cofactor synthesis gene 2). The human
cDNA clone MOCS1 involved in step 1 of the MoCo
biosynthetic pathway has been described elsewhere
(Reiss et al. 1998b).
Verification of the bicistronic arrangement of the
MOCS2A and MOCS2B ORFs in mammals was ob-
tained by analyzing other cDNA clones from human
brain (data not shown) or from the mouse. Figure 2
shows an alignment of the amino acid sequence of
MOCS2A and MOCS2B, respectively, with different ho-
mologous proteins found in the databases. In MOCS2A,
conserved amino acids are distributed over the entire
sequence, including a highly conserved motif of six
amino acids at the C-terminus with the consensus se-
quence PP(I/V/M/L)(S/A/T)GG. In the case of MOCS2B,
the alignment shows that the mammalian proteins in-
clude an N-terminal extension of ∼40 amino acids not
found in any of the eubacterial homologues and without
homology to any protein characterized in the database.
This extension represents the region of the MOCS2B
ORF overlapping the MOCS2A ORF. We will show be-
low that indeed the first ATG codon of this ORF is used
for the start of translation. The region with homology
to the eubacterial MOCS2B homologues starts after the
second in-frame ATG at position 323-325 (fig. 1).
To determine the size of the natural MOCS2 transcript
and to exclude that mRNAs representing only the
MOCS2A or MOCS2B ORF are generated by alterna-
tive or trans-splicing, we performed northern blot anal-
yses (fig. 3). In each tissue, only one transcript could be
detected that correlates with a calculated size of 1.35 kb
similar to the size of the characterized full-length
MOCS2 cDNA clone. No indications for alternative
splicing were detectable. The expression pattern follows
that of MOCS1 (Reiss et al. 1998b). Exposure after
MOCS2 hybrdization, however, was 50# prolonged as
compared with the actin control. At such a low expres-
sion level the question of tissue distribution must be
addressed cautiously.
To determine whether the proteins corresponding to
the two ORFs present in tMOCS2 (transcript of wild-
type MOCS2 cDNA) could be synthesized independently
of each other, various transcripts were tested by in vitro
translation (fig. 4). The two proteins synthesized by
tMOCS2 were 10 kDa and 21 kDa, and correspond in
size to MOCS2A and MOCS2B, respectively. A mutated
MOCS2A start codon in transcript tMOCS2A* abol-
ished the band at the position of 10 kDa, whereas the
21-kDa protein was synthesized in large amounts. With
tMOCS2B*, carrying a mutated MOCS2B start codon,
the 10-kDa protein was synthesized as efficiently as with
tMOCS2. No band was detected at the level of the 21-
kDa protein. In tMOCS2DAB, which begins within the
MOCS2B ORF, both bands were absent. Transcript
tMOCS2DA, which begins within the MOCS2A ORF,
yielded only the 21-kDa protein. To further verify that
the 21-kDa protein was synthesized from the first AUG
present in the corresponding ORF, the protein after SDS-
PAGE purification was submitted to CNBr treatment,
which cleaves after methionine residues. This cleavage
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Figure 3 Northern blot analysis of the human MOCS2 gene.
Results of reprobing with human b-actin are shown at the bottom.
Poly A mRNA was derived from heart (lane 1), brain (lane 2), pla-
centa (lane 3), lung (lane 4), liver (lane 5), skeletal muscle (lane 6),
kidney (lane 7), and pancreas (lane 8). The sizes of the mRNA markers
are indicated to the left.
Figure 4 Fluorogram of the in vitro translation products of cap-
ped transcripts in a rabbit reticulocyte lysate with [35S]methionin. Lane
1, Translation in the absence of transcript. Lanes 2–6, Translation in
the presence of tMOCS2, tMOCS2A*, tMOCS2B*, tMOCS2DA, and
tMOCS2DAB, respectively. The products were analyzed on a 16.5%
polyacrylamide-Tricine/SDS gel system. The sizes of the products syn-
thesized (left) and the sizes and positions of [14C] protein markers
(Amersham) run on a parallel lane (right) are given.
yielded the expected three peptides of 3.8 kDa, 6.9 kDa,
and 10.1 kDa (data not shown).
If the 21-kDa protein is produced from capped t-
MOCS2 by leaky scanning, its synthesis should be hin-
dered by the addition of cap analogue (m7GTP) to the
same extent as synthesis of the 10-kDa protein. This
would normally not be the case if synthesis of the 21-
kDa protein occurred by internal initiation. As shown
in figure 5, translation of capped tMOCS2 in the pres-
ence of cap analogue dramatically reduced the amount
of the two proteins synthesized.
Discussion
With ∼30% identity, the degree of homology between
the human proteins and their E. coli homologues is as
high as between different eukaryotic proteins involved
in MoCo biosynthesis characterized hitherto and their
E. coli homologues (Hoff et al. 1995; Stallmeyer et al.
1995; Reiss et al. 1998b). Furthermore, an alignment of
the human MOCS2A and MOCS2B amino acid se-
quences with the homologous proteins of eubacterial
and eukaryotic origin demonstrates that, within the
mammalian sequences, the same amino acids are con-
served as within the sequences of the corresponding eu-
bacterial MoaD and MoaE proteins.
The bicistronic structure of the mammalian MOCS2
gene contrasts with the situation in Arabidopsis thaliana
and Caenorhabditis elegans, in which the small and large
subunits of the MPT-synthase are encoded by separate
genes (Wilson et al. 1994; reviewed by Mendel [1997]).
In principle, two mechanisms could enable translation
initiation at a 3′-located ORF in eukaryotic mRNAs. The
first possibility is through leaky scanning (Kozak 1989),
in which 40S ribosomal subunits bind at the capped 5′
end of the mRNA and scan downstream to the first AUG
codon. If this AUG is in an unfavorable codon context,
it might be bypassed by some 40S subunits that continue
scanning downstream to initiate at the next available
AUG in a more favorable context. As opposed to the
situation in viral mRNAs, in eukaryotes, leaky scanning
of bicistronic mRNAs is rare and is generally used by
some ribosomes to bypass short nonoverlapping 5′-prox-
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Figure 5 Effect of the cap analogue m7GTP on the translation
of capped transcripts. Translation in a rabbit reticulocyte lysate with
[35S]methionine of the capped tMOCS2 (lanes 1, 2) or tMOCS2A*
(lanes 3, 4) was carried out in the absence (; lanes 1, 3) or in the
presence (, lanes 2, 4) of m7GTP. The sizes of the products analyzed
on a 16.5% polyacrylamide-Tricine/SDS gel system are indicated to
the left, and the sizes and positions of [14C] protein markers run on a
parallel lane are given to the right of the fluorogram.
imal ORFs and reach the major ORF (reviewed by Ge-
balle [1996]). Because the AUG of the MOCS2A ORF
is contained within a rather favorable context
(GGCGGGAUGGUG), the reason why some ribosomes
bypass this initiation codon is unclear.
The other mechanism that allows translation of 3′-
located ORFs is a cap-independent mechanism, char-
acterized by internal ribosome initiation facilitated by
the presence of an internal ribosome entry site (IRES)
within the 5′ UTR of the mRNA. IRES-dependent trans-
lation initiation has been described for picornavirus
RNA (Jang et al. 1988; Pelletier and Sonnenberg 1988)
and some eukaryotic cellular mRNAs (reviewed by
Iizuka et al. [1995]), but can be ruled out for MOCS2B
expression because it is sensitive to cap analogue.
Another scenario that needed to be envisaged was
frameshifting. A 1 frameshift event would lead to the
synthesis of a MOCS2A/B frameshift protein of 27 kDa,
in addition to MOCS2A. A first examination of the level
of MOCS2A and MOCS2B synthesized indicates that
they are produced in similar amounts, which is an ar-
gument against frameshifting, the efficiency of which is
generally !30% in eukaryotic RNA viruses (discussed
by ten Dam [1995]) and 19% in the case of mammalian
ornithine decarboxylase antizyme (Matsufuji et al.
1995). Analysis of the peptides obtained from a CNBr
cleavage of the 21-kDa MOCS2B protein, synthesized
in vitro in the presence of [35S]cysteine, clearly demon-
strated that frameshifting can be ruled out as a mech-
anism leading to the translation of the 3′-located ORF.
Whereas in eubacteria functionally related proteins
are often encoded from bicistronic or polycistronic
mRNAs, eukaryotic mRNAs are generally monocis-
tronic. Examples of eukaryotic bicistronic mRNAs are
nearly exclusively known for viral systems. In very few
cases bicistronic mRNAs have been described in eukar-
yotic cellular systems (Lee 1991; Andrews et al. 1996;
Ritchie and Wang 1997). The mechanism leading to the
translation of the 3′-located ORF is unknown. Interest-
ingly, the human MOCS1 gene catalyzing the first step
of the molybdenum cofactor biosynthesis is also bicis-
tronic (Reiss et al. 1998b). Nevertheless, the two
MOCS1 ORFs are arranged in tandem, and the mode
of MOCS1B expression is presumed to be translation
reinitiation. Our in vitro experiments with MOCS2 sug-
gest leaky scanning as the mode of translation for the
second protein. Thus, the mode of translation does not
appear to be the explanation for the unusual architecture
of the MOCS genes.
We have already reported that mutations leading to
MoCo deficiency type A were found in both ORFs of
the MOCS1 transcript and that all identified mutations
were “severe” mutations (i.e., frameshift mutations;
Reiss et al. 1998a, 1998b). Similar results are described
for MoCo deficiency type B and the MOCS2 gene in the
accompanying paper by Reiss et al. (1999 [in this issue]).
These observations support the idea that in vivo ex-
pression of both ORFs is necessary for a normal phe-
notype. The absence of leaky mutations—which would
allow for a partial enzyme activity—in the patients is in
agreement with a very low expression level and perhaps
also the possibility of unusual and otherwise inefficient
ways of expression, such as translation reinitiation or
leaky scanning.
For essential metabolic pathways, the evolution of a
multifunctional eukaryotic fusion protein comprising the
functions of two separate E. coli proteins has already
been demonstrated, for example, for MoCo biosynthesis
in plants (Stallmeyer et al. 1995), and in Aspergillus
nidulans (Unkles et al. 1997) for fatty acid synthesis
(Amy et al. 1992) and for pyrimidine biosynthesis (Da-
vidson et al. 1993). One reason for the development of
such gene fusions might be the colinear regulation of
gene expression and also the guaranteed proximity of
the interacting proteins, thus leading to an evolutionary
advantage for the organism. The latter aspect of micro-
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compartmentalization can be expected to be of greater
importance for low substrate concentrations, such as in
MoCo biosynthesis.
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